Study on Point-fo-care diagnostics market dominated by lateral flow assays, dipsticks, micro fluidics, molecular diagnostics, immunoassays. Growing advancements in technology & increasing initiatives of market players for developing POC molecular diagnostic products propelling demand for molecular diagnostics.
Point-of-care diagnostics market growing at 10% CAGR and projected to reach US$ 38.13 Billion by 2022 from US$ 23.71 Billion in 2017, at a CAGR of during forecast period. Factors like high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, & rising preference for home healthcare across globe are increasing the adoption of POC diagnostic products globally.
Download Free Brochure of Point-of-Care Diagnostics Market spread across 226 Pages, Profiling 15 Companies and Supported with 129 Tables and 36 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1366377 .
Point-of-care diagnostics segment expected to be fastest-growing segment during forecast period. The infectious disease testing products segment is expected to grow at the highest CAGR during the forecast period. The growing patient population base and increasing availability and awareness about infectious disease POC testing products are the major factors contributing to the segment’s growth.
“The glucose monitoring products segment is expected to command the largest share of the POC diagnostics market in 2017.”
Point-of-care Diagnostics Market based on product, platform, mode, end user, and region. The report also studies factors affecting market growth; it analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. The report forecasts the revenue of market segments with respect to the four key regions and respective countries.
Collect More Information and Details on Point-of-Care Diagnostics Market with Top Trends and Global Forecast at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1366377 .
Top players point-of-care diagnostics market are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio (US), Sekisui Diagnostics (US), Nova (US), EKF Diagnostics (UK), Accu BioTech (China), and Trinity Biotech (US).
Point-of-Care Diagnostics Market, By Platform
2 Lateral Flow Assays (Immunochromatography Tests)
5 Molecular Diagnostics
Get Discount on “Point-of-Care/Rapid Diagnostics Market by Testing (Glucose, Lipids, HbA1c, HCV, HIV, Influenza, Urinalysis, Hematology, Cancer, Pregnancy, PT/INR), Platform (Lateral Flow, Immunoassay), Mode (Prescription, OTC), End-User – Global Forecast to 2022” Report Now at http://www.rnrmarketresearch.com/contacts/discount?rname=1366377 .
This report studies the point-of-care diagnostics market based on product, platform, mode, end user, and region. The report also studies factors affecting market growth; it analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders.
Reasons to Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis—market ranking analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the point-of-care diagnostics market, and high-growth regions and their drivers, restraints, challenges, and opportunities.
About Us –
RnRMarketResearch is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
Contact Number: + 1 888 391 5441
Email Id – [email protected]